Literature DB >> 27125681

Advances in surgery for movement disorders.

Nathan C Rowland1, Francesco Sammartino1, Andres M Lozano1.   

Abstract

Movement disorder surgery has evolved throughout history as our knowledge of motor circuits and ways in which to manipulate them have expanded. Today, the positive impact on patient quality of life for a growing number of movement disorders such as Parkinson's disease is now well accepted and confirmed through several decades of randomized, controlled trials. Nevertheless, residual motor symptoms after movement disorder surgery such as deep brain stimulation and lack of a definitive cure for these conditions demand that advances continue to push the boundaries of the field and maximize its therapeutic potential. Similarly, advances in related fields - wireless technology, artificial intelligence, stem cell and gene therapy, neuroimaging, nanoscience, and minimally invasive surgery - mean that movement disorder surgery stands at a crossroads to benefit from unique combinations of all these developments. In this minireview, we outline some of these developments as well as evidence supporting topics of recent discussion and controversy in our field. Moving forward, expectations remain high that these improvements will come to encompass an even broader range of patients who might benefit from this therapy and decrease the burden of disease associated with these conditions.
© 2016 International Parkinson and Movement Disorder Society. © 2016 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  -Parkinson's disease; deep brain stimulation; dystonia; essential Tremor; technology

Mesh:

Year:  2016        PMID: 27125681     DOI: 10.1002/mds.26636

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

Review 2.  Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease.

Authors:  Sabato Santaniello; John T Gale; Sridevi V Sarma
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-20

Review 3.  Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.

Authors:  Joaquin A Vizcarra; Miguel Situ-Kcomt; Carlo Alberto Artusi; Andrew P Duker; Leonardo Lopiano; Michael S Okun; Alberto J Espay; Aristide Merola
Journal:  J Neurol       Date:  2018-06-16       Impact factor: 4.849

4.  Deciphering the Network Effects of Deep Brain Stimulation in Parkinson's Disease.

Authors:  Muthuraman Muthuraman; Sergiu Groppa; Gabriel Gonzalez-Escamilla; Nabin Koirala; Manuel Bange; Martin Glaser; Bogdan Pintea; Christian Dresel; Günther Deuschl
Journal:  Neurol Ther       Date:  2022-01-09

5.  Research trends and frontiers in exercise for movement disorders: A bibliometric analysis of global research from 2010 to 2021.

Authors:  Ji-Wei Chen; Yue Guan; Yi-Li Zheng; Kun Zhu
Journal:  Front Aging Neurosci       Date:  2022-09-07       Impact factor: 5.702

6.  Multiple Microelectrode Recordings in STN-DBS Surgery for Parkinson's Disease: A Randomized Study.

Authors:  Silje Bjerknes; Mathias Toft; Ane E Konglund; Uyen Pham; Trine Rygvold Waage; Lena Pedersen; Mona Skjelland; Ira Haraldsen; Stein Andersson; Espen Dietrichs; Inger Marie Skogseid
Journal:  Mov Disord Clin Pract       Date:  2018-05-08

7.  Forniceal deep brain stimulation in severe Alzheimer's disease: A case report.

Authors:  Wei Lin; Wei-Qi Bao; Jing-Jie Ge; Li-Kun Yang; Zhi-Pei Ling; Xin Xu; Jie-Hui Jiang; Chuan-Tao Zuo; Yu-Hai Wang
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.